Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
04/19/2024 11:00 PM
Pennsylvania House of Representatives
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=H&SPick=20150&cosponId=15772
Share:
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


House of Representatives
Session of 2015 - 2016 Regular Session

MEMORANDUM

Posted: December 10, 2014 03:41 PM
From: Representative Jim Cox and Rep. Ed Gainey
To: All House members
Subject: Medical Cannabis Legislation
 
In the near future, we will introduce the House Companion bill to the medical cannabis bill that passed with overwhelming support (43-7) in the Senate in September of 2014 (S.B. 1182, P.N. 2324). This legislation will allow physicians in Pennsylvania to recommend medicinal cannabis to patients who would medically benefit from such a treatment. There are currently 21 states and the District of Columbia that have similar laws.

Similar legislation was introduced in the House last session with the following co-sponsors: Cox, Barrar, Briggs, V. Brown, Brownlee, Caltagirone, Carroll, Cohen, Davis, DeLissio, DeLuca, Donatucci, Ellis, Everett, Fabrizio, Flynn, Frankel, Gergely, Goodman, Harkins, C. Harris, K. Boyle, W. Keller, Kim, Kortz, Mahoney, Marshall, McCarter, McNeill, Millard, Moul, Mullery, Murt, O’Brien, O’Neill, Oberlander, Ravenstahl, Reed, Regan, Roae, Rozzi, Sabatina, Samuelson, Santarsiero, Schlossberg, Sturla, Tallman, and Watson.

The Senate-passed version of S.B. 1182 represented months of hearings, discussions, changes, and compromises with one goal in mind: helping those with medical challenges – especially children with seizure disorders – to benefit from a medicinal strain of cannabis. Some children suffer hundreds of seizures a day, making normal childhood development impossible and forcing parents to helplessly watch their children suffer. Prescribed narcotic cocktails of highly addictive and dangerous drugs have little effect on these disorders and often provide only a few weeks or months of pause in the decline of a child’s health.

The emphasis of this legislative effort has focused on a strain of cannabis very high in Cannabidiols (CBD), a compound with anti-inflammatory and antioxidant properties, and very low in Tetrahydrocannabinols (THC), the psychoactive ingredient in cannabis. Called “Charlotte’s Web,” this strain has been used to treat disorders with dramatic results that are rapid, non-intoxicating, and free of side effects for children using this medicine, as seen in this video: http://www.youtube.com/watch?v=CiShwotFJR8.

This legislation would allow patients who have a recommendation from their doctor to purchase and use medical cannabis from centers licensed by a new State Board of Medical Cannabis Licensing. The entire process would be regulated by licensing: medical cannabis growers, processors, and dispensers.

In addition to promulgating regulations, the board would also be empowered to adopt a schedule of civil penalties for operating without a current license or occupation permit or for other violations. The board would have the power to revoke licenses for violations, refusing to adhere to an order of the board, or for conviction of a criminal offense. The board would also be able to issue cease and desist orders, order restitution, or issue a letter of reprimand or censures.

Prohibitions in our legislation include:
  • No individual may smoke medical cannabis
  • No individual may undertake any task under the influence if it would constitute negligence or professional malpractice
  • No individual may operate or drive a motor vehicle, aircraft, motor boat, or heavy machinery with more than 10 nanograms of THC in their system
The 2014 fiscal note found “no adverse fiscal impact” to the Commonwealth due to licensing fees ($50,000 per license for growers, processors, and distributors), renewal license fees ($5,000), and access card fees ($100 application fees and $50 annual renewal fees).

It is cruel and irrational to deny people medicine to alleviate their suffering – especially when we routinely prescribe far more addictive, powerful, and toxic medications for the same conditions. I hope you will join us in ensuring our sick friends and family members will have access to the best medicine available to relieve their pain and suffering.

Thank you!

.